Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: Dependence on ErbB1 expression and Src activation

Experimental Cell Research

Volumn 280, Issue 1, 2002, Pages 134-147

  Kim, Yong Nyun ^a   Dam, Phuongan ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Caveolin; EGF receptor; ErbB family; Human cancer; Src; Tyrosine phosphorylation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CAVEOLIN 1; COLCHICINE; CYTOCHALASIN D; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN; PROTEIN INHIBITOR; PROTEIN KINASE P60; PYRROLE DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR BIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA; TEMPERATURE;

MURINAE;

EID: 0036033549     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5623     Document Type: Article

References (53)

1. Anderson, R. G. W. (1998). The caveolae membrane system [Review]. Ann. Rev. Biochem. 67, 199-225.
2. Biscardi, J. S., Belsches, A. P., and Parsons, S. J. (1998). Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol. Carcino. 21, 261-272.
3. Biscardi, J. S., Maa, M. C., Tice, D. A., Cox, M. E., Leu, T. H., and Parsons, S. J. (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335-8343.
4. Biscardi, J. S., Tice, D. A., and Parsons, S. J. (1999). c-Src, receptor tyrosine kinases, and human cancer [Review]. Adv. Cancer Res. 76, 61-119.
5. Bowers, G., Reardon, D., Hewitt, T., Dent, P., Mikkelsen, R. B., Valerie, K., Lammering, G., Amir, C., and Schmidt-Ullrich, R. K. (2001). The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene 20, 1388-1397.
6. Burr, J. G., Dreyfuss, G., Penman, S., and Buchanan, J. M. (1980). Association of the src gene product of Rous sarcoma virus with cytoskeletal structures of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 77, 3484-3488.
7. Carpenter, G., and Cohen, S. (1990). Epidermal growth factor. J. Biol. Chem. 265, 7709-7712.
8. Ciardiello, F., and Tortora, G. (1998). Interactions between the epidermal growth factor receptor and type I protein kinase A: Biological significance and therapeutic implications. Clin. Cancer Res. 4, 821-828.
9. Cohen, S., Carpenter, G., and King, L., Jr. (1980). Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J. Biol. Chem. 255, 4834-4842.
10. Cohen, S., Ushiro, H., Stoscheck, C., and Chinkers, M. (1982). A native 170, 000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J. Biol. Chem. 257, 1523-1531.
11. Couet, J., Li, S. W., Okamoto, T., Scherer, P. E., and Lisanti, M. P. (1997). Molecular and cellular biology of caveolae-Paradoxes and plasticities. Trends Cardiovasc. Med. 7, 103-110.
12. Dickson, R. B., Johnson, M. D., el-Ashry, D., Shi, Y. E., Bano, M., Zugmaier, G., Ziff, B., Lippman, M. E., and Chrysogelos, S. (1993). Breast cancer: Influence of endocrine hormones, growth factors and genetic alterations. Adv. Exp. Med. Biol. 330, 119-141.
13. Engelman, J. A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D. S., and Lisanti, M. P. (1998). Caveolin-mediated regulation of signaling along the P42/44 Map kinase cascade in vivo-A role for the caveolin-scaffolding domain. FEBS Lett. 428, 205-211.
14. Engelman, J. A., Wykoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T., and Lisanti, M. P. (1997). Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272, 16374-16381.
15. Fabricant, R. N., De Larco, J. E., and Todaro, G. J. (1977). Nerve growth factor receptors on human melanoma cells in culture. Proc. Natl. Acad. Sci. USA 74, 565-569.
16. Fan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., and Mendelsohn, J. (1995). Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell Biol. 131, 235-242.
17. Furuchi, T., and Anderson, R. G. (1998). Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273, 21099-21104.
18. Galbiati, F., Volonte, D., Engelman, J. A., Watanabe, G., Burk, R., Pestell, R. G., and Lisanti, M. P. (1998). Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17, 6633-6648.
19. Gill, G. N., and Lazar, C. S. (1981). Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 293, 305-307.
20. Glenney, J. R., Jr., Chen, W. S., Lazar, C. S., Walton, G. M., Zokas, L. M., Rosenfeld, M. G., and Gill, G. N. (1988). Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell 52, 675-684.
21. Glenney, J. R., Jr., and Zokas, L. (1989). Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108, 2401-2408.
22. Grandis, J. R., and Tweardy, D. J. (1993). Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 53, 3579-3584.
23. Gronowski, A. M., and Bertics, P. J. (1993). Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: Analysis of intact and carboxy-terminally truncated receptors. Endocrinology 133, 2838-2846.
24. Gronowski, A. M., and Bertics, P. J. (1995). Modulation of epidermal growth factor receptor interaction with the detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity. Endocrinology 136, 2198-2205.
25. Hamaguchi, M., and Hanafusa, H. (1987). Association of p60src with Triton X-100-resistant cellular structure correlates with morphological transformation. Proc. Natl. Acad. Sci. USA 84, 2312-2316.
26. Jackowski, M. M., Swift, L. L., Cohen, S., and McKanna, J. A. (1990). Morphologic changes in human carcinoma cells (A-431) stimulated by epidermal growth factor: Effect of cholesterol and low-density lipoproteins on the ruffling response. J. Cell. Physiol. 142, 458-468.
27. Kim, Y. N., Wiepz, G. J., Guadarrama, A. G., and Bertics, P. J. (2000). Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1-Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal, growth factor receptor status. J. Biol. Chem. 275, 7481-7491.
28. Koleske, A. J., Baltimore, D., and Lisanti, M. P. (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92, 1381-1385.
29. Lee, H., Volonte, D., Galbiati, F., Iyengar, P., Lublin, D. M., Bregman, D. B., Wilson, M. T., Campos-Gonzalez, R., Bouzahzah, B., Pestell, R. G., Scherer, P. E., and Lisanti, M. P. (2000). Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol. Endocrinol. 14, 1750-1775.
30. Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B., and Schnitzer, J. E. (1998). Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16, 1391-1397.
31. Li, J., Kim, Y. N., and Bertics, P. J. (2000). Platelet-derived growth factor-stimulated migration of murine fibroblasts is associated with epidermal growth factor receptor expression and tyrosine phosphorylation. J. Biol. Chem. 275, 2951-2958.
32. Li, J., Lin, M. L., Wiepz, G. J., Guadarrama, A. G., and Bertics, P. J. (1999). Integrin-mediated migration of murine B82L fibro-blasts is dependent on the expression of an intact epidermal growth factor receptor. J. Biol. Chem. 274, 11209-11219.
33. Li, S. W., Seitz, R., and Lisanti, M. P. (1996). Phosphorylation of caveolin by Src tyrosine kinases-The Alpha-isoform of caveolin is selectively phosphorylated by V-Src in vivo. J. Biol. Chem. 271, 3863-3868.
34. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. (1985). Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313, 144-147.
35. Liu, P. S., Ying, Y. S., and Anderson, R. G. W. (1997). Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc. Natl. Acad. Sci. USA 94, 13666-13670.
36. Luttrell, D. K., Lee, A., Lansing, T. J., Crosby, R. M., Jung, K. D., Willard, D., Luther, M., Rodriguez, M., Berman, J., and Gilmer, T. M. (1994). Involvement of pp60c-src with two major signaling pathways in human breast cancer. Proc. Natl. Acad. Sci. USA 91, 83-87.
37. Luttrell, D. K., Luttrell, L. M., and Parsons, S. J. (1988). Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol. Cell. Biol. 8, 497-501.
38. Maa, M. C., Leu, T. H., McCarley, D. J., Schatzman, R. C., and Parsons, S. J. (1995). Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. USA 92, 6981-6985.
39. Maurizi, M., Almadori, G., Ferrandina, G., Distefano, M., Romanini, M. E., Cadoni, G., Benedetti-Panici, P., Paludetti, G., Scambia, G., and Mancuso, S. (1996). Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br. J. Cancer 74, 1253-1257.
40. Mineo, C., James, G. L., Smart, E. J., and Anderson, R. G. W. (1996). Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271, 11930-11935.
41. Nomura, R., and Fujimoto, T. (1999). Tyrosine-phosphorylated caveolin-1: Immunolocalization and molecular characterization. Mol. Biol. Cell 10, 975-986.
42. Okamoto, T., Schlegel, A., Scherer, P. E., and Lisanti, M. P. (1998). Caveolins, a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane [Review]. J. Biol. Chem. 272, 5419-5422.
43. Oude Weernink, P. A., Ottenhoff-Kalff, A. E., Vendrig, M. P., van Beurden, E. A., Staal, G. E., and Rijksen, G. (1994). Functional interaction between the epidermal growth factor receptor and c-Src kinase activity. FEBS Lett. 352, 296-300.
44. Riese, D. J., and Stern, D. F. (1998). Specificity within the EGF family erbB receptor family signaling network. Bioessays 20, 41-48.
45. Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., and Carraway, K. L., 3rd. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 269, 14661-14665.
46. Thompson, T. C. (1998). Metastasis-related genes in prostate cancer. The role of caveolin-1 [Review]. Cancer Metastasis Rev. 17, 439-442.
47. Tice, D. A., Biscardi, J. S., Nickles, A. L., and Parsons, S. J. (1999). Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 96, 1415-1420.
48. Velu, T. J., Beguinot, L., Vass, W. C., Willingham, M. C., Mer-lino, G. T., Pastan, I., and Lowy, D. R. (1987). Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238, 1408-1410.
49. Weernink, P. A., and Rijksen, G. (1995). Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J. Biol. Chem. 270, 2264-2267.
50. Wilde, A., Beattie, E. C., Lem, L., Riethof, D. A., Liu, S. H., Mobley, W. C., Soriano, P., and Brodsky, F. M. (1999). EGF receptor signaling stimulates SRC kinase phosphorylation of clathrin, influencing clathrin redistribution and EGF uptake. Cell 96, 677-687.
51. Yang, G., Addai, J., Ittmann, M., Wheeler, T. M., and Thompson, T. C. (2000). Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clin. Cancer Res. 6, 3430-3433.
52. Yang, G., Truong, L. D., Timme, T. L., Ren, C. Z., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., and Thompson, T. C. (1998). Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4, 1873-1880.
53. Yarden, Y., and Sliwkowski, M. X. (2001). Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127-137.